Isotretinoin Capsule
Product Images NDC 59651-635

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Isotretinoin (NDC 59651-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Isotretinoin Fig1)

Figure1 (Isotretinoin Fig1)
A line graph showing mean lesion count over time from baseline to week 20, comparing two groups labeled as Isotretinoin Capsules and Isotretinoin. The x-axis represents analysis visits at baseline, week 4, 8, 12, 16, and 20. The y-axis shows mean lesion count, which decreases steadily over time for both groups.*
FDA Label Image

Figure10 (Isotretinoin Fig10)

Figure10 (Isotretinoin Fig10)
The image shows the packaging label for Isotretinoin Capsules, USP, 35 mg, an oral prescription drug by Aurobindo Pharma Limited. The label highlights it as Rx only and contains 30 capsules divided into 3 packs of 10. It includes warnings about birth defects and instructs pharmacists to dispense the Medication Guide separately to patients. The label also provides storage instructions, manufacturer details, and barcode information.*
FDA Label Image

Figure11 (Isotretinoin Fig11)

Figure11 (Isotretinoin Fig11)
The image shows the packaging label for Isotretinoin Capsules, USP 35 mg by Aurobindo Pharma Limited. It is a prescription pack containing 10 oral capsules. The label includes warnings for female patients about serious birth defects, usage instructions with pull tab details, storage information, and a reminder that the capsules should not be taken if pregnant or may become pregnant during treatment.*
FDA Label Image

Figure12 (Isotretinoin Fig12)

Figure12 (Isotretinoin Fig12)
Label for Isotretinoin Capsules, USP 40 mg oral capsules by Aurobindo Pharma Limited. The label indicates a 30-capsule count (3 x 10 prescription packs) and includes warnings about birth defects with a pregnancy caution symbol. The label also contains pharmacist reminders, dispensing instructions, storage conditions, and barcode.*
FDA Label Image

Figure13 (Isotretinoin Fig13)

Figure13 (Isotretinoin Fig13)
Label for Isotretinoin Capsules USP 40 mg oral capsules from Aurobindo Pharma Limited. The label includes a prescription pack of 10 capsules and contains detailed warnings about use by female patients, including pregnancy risks and birth defects. Instructions for removing individual capsules from the blister pack are provided, as well as storage conditions and pregnancy-related illustrations. The label emphasizes careful reading of the medication guide and FDA pregnancy prevention program compliance.*
FDA Label Image

Figure2 (Isotretinoin Fig2)

Figure2 (Isotretinoin Fig2)
Packaging label for Isotretinoin Capsules, USP 10 mg by Aurobindo Pharma Limited. The carton contains 30 capsules (3x10 prescription packs) and includes warnings about birth defects and pregnancy. The label instructs pharmacists to dispense the medication guide separately to each patient and features storage instructions and distribution details.*
FDA Label Image

Figure3 (Isotretinoin Fig3)

Figure3 (Isotretinoin Fig3)
Packaging label for Isotretinoin Capsules, USP, 10 mg, oral capsules in a 10 capsule prescription pack. The label includes warnings that female patients should not take the drug if pregnant due to severe birth defects risk. It shows detailed usage instructions, safety information, and storage conditions. The labeler is Aurobindo Pharma Limited.*
FDA Label Image

Figure4 (Isotretinoin Fig4)

Figure4 (Isotretinoin Fig4)
Isotretinoin Capsules USP 20 mg oral medication carton by Aurobindo Pharma Limited. The label states 'Rx only,' contains 30 capsules in 3x10 prescription packs, and includes warnings about birth defects and pregnancy. The package instructs pharmacists to dispense the medication guide separately and provides storage, distribution, and dosing information.*
FDA Label Image

Figure5 (Isotretinoin Fig5)

Figure5 (Isotretinoin Fig5)
Packaging label for ISOTRETINOIN Capsules, USP 20 mg by Aurobindo Pharma Limited, containing 10 capsules in a prescription pack. The label includes warnings emphasizing that female patients should not get pregnant while using this medication due to the risk of severe birth defects. Directions for capsule removal and important patient safety information are also present.*
FDA Label Image

Figure6 (Isotretinoin Fig6)

Figure6 (Isotretinoin Fig6)
Isotretinoin Capsules, USP 25 mg oral capsules packaging label by Aurobindo Pharma Limited. The label indicates 30 capsules (3x10 prescription packs) per carton. It includes warnings about birth defects and pregnancy, dispensing instructions for pharmacists, and storage conditions. Distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Figure7 (Isotretinoin Fig7)

Figure7 (Isotretinoin Fig7)
Isotretinoin Capsules, USP 25 mg oral capsules in a 10-capsule prescription pack by Aurobindo Pharma Limited. The label contains detailed patient instructions and warnings specifically for female patients, emphasizing severe birth defects risks and precautions to avoid pregnancy during treatment. Directions for removing capsules from the pack are also included, along with storage instructions.*
FDA Label Image

Figure9 (Isotretinoin Fig8)

Figure9 (Isotretinoin Fig8)
Label for Isotretinoin Capsules, USP 30 mg by Aurobindo Pharma Limited. The package contains 30 capsules divided into three 10-capsule prescription packs. The label includes warnings about birth defects and instructions for pharmacists regarding dispensing and prescription packs. The product is intended for oral use and is prescription only.*
FDA Label Image

Figure9 (Isotretinoin Fig9)

Figure9 (Isotretinoin Fig9)
ISOTRETINOIN 30 mg oral capsules packaging label from Aurobindo Pharma Limited. The label includes dosage warnings emphasizing that the drug causes severe birth defects and must not be used by pregnant patients. Instructions for use and removal of capsules from the blister pack are visible. The label also shows patient safety information, storage conditions, and contains a barcode along with the NDC 59651-634-10. This is a prescription pack containing 10 capsules.*
FDA Label Image

Structure (Isotretinoin Str)

Structure (Isotretinoin Str)
Chemical structure diagram of isotretinoin, showing a polyene chain with a carboxylic acid group at one end and a cyclic ring at the other.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.